Harvard Bioscience, Inc. has announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees. Additionally, Katherine Eade has been named Lead Independent Director of the board. Thomas Loewald has retired from the board after serving since October 2017.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9462072-en) on June 02, 2025, and is solely responsible for the information contained therein.